1212-结直肠癌KRAS抑制剂耐药图谱 episode artwork

EPISODE · Jul 1, 2026 · 20 MIN

1212-结直肠癌KRAS抑制剂耐药图谱

from 聊聊Sci

这篇文献综述探讨了大肠癌在接受KRAS G12C抑制剂治疗时产生耐药性的复杂机制。研究重点介绍了Alonso及其同事的发现,指出肿瘤通过基因突变和转录组适应(如上皮细胞状态切换和促炎通路激活)来逃避药物作用。通过空间转录组分析,科学家们观察到同一肿瘤内部存在高度的异质性,不同区域表现出截然不同的适应性程序。治疗过程中,肿瘤细胞会从最初的再生状态转变为干细胞或潘氏细胞表型,并最终形成持久的炎症环境。这种动态的细胞塑性不仅挑战了传统的单一活检诊断,还为开发结合免疫或抗炎通路的联合疗法提供了理论依据。总之,该研究强调了在精准医疗中整合空间组织信息和表型成像对于克服耐药性的重要性。References:White M, Campbell AD, Sansom OJ. The cartography of KRAS inhibitor resistance in colorectal cancer. Cancer Cell. 2026 Jun 11:S1535-6108(26)00255-2. doi: 10.1016/j.ccell.2026.05.010. Epub ahead of print. PMID: 42276046.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Jul 1, 2026

Embed this episode

Ready to play

1212-结直肠癌KRAS抑制剂耐药图谱

0:00 20:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 20 minutes long.

When was this 聊聊Sci episode published?

This episode was published on July 1, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!